Changes in Lipid Levels and Incidence of Cardiovascular Events Following Tofacitinib Treatment in Patients with Psoriatic Arthritis: A Pooled Analysis Across Phase 3 and Long-Term Extension Studies
Arthritis Care Res (Hoboken) 2019;71(10):1387–95
View and download slide summaries of the latest original articles focusing on therapies in immune-mediated inflammatory diseases including rheumatology, dermatology, and gastroenterology. All materials produced by the team are subsequently reviewed and approved by individual Steering Committee members.
Arthritis Care Res (Hoboken) 2019;71(10):1387–95
Arthritis Res Ther. 2019 Apr 18;21(1):102
Lancet. 2018 Dec 1;392(10162):2367-2377. DOI 10.1016/ S0140-6736(18)32483-8
Pharmacoeconomics. 2018 Dec;36(12):1427-1437. doi: 10.1007/s40273-018-0677-7
Pharmacoeconomics 2018 Jul; 36(7):769–78
Please click the links below to go to the CSF review of each paper.
Nat Rev Drug Discov 2017;16:843–62 DOI: 10.1038/nrd.2017.201
N Engl J Med 2017; 377:1537-50. DOI: 10.1056/NEJMoa1615975
N Engl J Med 2017;377:1525–36.
Drug Saf. 2016 June 9; 39:755–762; DOI 10.1007/s40264-016-0431-z [Epub ahead of print]